Feature | Cath Lab | May 06, 2021 | By Dave Fornell, Editor

SCAI 2021 Late-breaking Clinical Study Results

SCAI 2021 late-breaking presentations included the data on the Medtronic Harmony transcatheter pulmonary valve, cutting radial access hemostasis time by 50 percent, improving cardiogenic shock survival to 71 percent, and data showing very high mortality in COVID patients who suffer a STEMI heart attack. #SCAI21 #SCAI2021

SCAI 2021 late-breaking presentations included the data on the Medtronic Harmony transcatheter pulmonary valve, cutting radial access hemostasis time by 50 percent, improving cardiogenic shock survival to 71 percent, and data showing very high mortality in COVID patients who suffer a STEMI.


April 29, 2021 — Here is the list of late-breaking study presentations and links to articles about each of them from the Society for Cardiovascular Angiography and Interventions (SCAI) 2021 Scientific Sessions Virtual Conference, which took place April 28 - May 1. Sessions share the latest advances in interventional cardiology and featured late-breaking clinical research. Find the entire virtual meeting program and links to the archived on-demand sessions at www.scai.org/scai2021.

SCAI 2021 Late-Breaking Studies:

Update on the North American COVID-19 Myocardial Infarction (NACMI) Registry — one-third of patients die, effects large percentage of minorities, 20% do not have cuplit lesions — Presented by Payam Dehghani, M.D., University of Saskatchewan

SCAI Shock Classification for Mortality Risk Stratification: Survey of Published Evidence. Presented by Jacob Jentzer, M.D., Mayo Clinic.

Final Results From The National Cardiogenic Shock Initiative — Survival With Impella Increased to 71%. Presented by Babar Basir, D.O., Henry Ford Health System.

Establishing the Optimal Duration of DAPT After PCI in High-Risk TWILIGHT-like patients with Acute Coronary Syndrome. Presented by Haoyu Wang, Fuwai Hospital, National Center for Cardiovascular Diseases

Study reveals need for equitable access of TAVR minimally invasive heart procedures. Presented by Ashwin Nathan, M.D., Hospital of the University of Pennsylvania

Study reveals patients in ISCHEMIA trial only represent small fraction of heart disease patients undergoing intervention, calling into question the study's application in real-world practice. Presented by Saurav Chatterjee, Northwell Health.

Safety and Efficacy of the Second Generation Robotic-Assisted System for Percutaneous Coronary Intervention: Final Results of the Multicenter PRECISION GRX Study in a real-world population across a spectrum of lesion complexity. Presented by Ehtisham Mahmud, M.D., UCS San Diego Health

Hospital-Level Percutaneous Coronary Intervention Performance with Simulated Risk Avoidance Strategies Did Not Necessarily Help Hospital Performance Scores. Presented by Ashwin Nathan, M.D., Hospital of the University of Pennsylvania

Radial Hemostasis Time Cut by 50 Percent With StatSeal in Combination With TR Band —reduces time to hemostasis following cardiac catheterization procedures and improves cath lab efficiency. Presented by Arnold Seto, M.D., UCI Health.

Breakthrough technology provides advanced, non-invasive treatment option for patients with congenital heart disease — One-year Results of the Harmony Transcatheter Pulmonary Valve Trial . Presented by Thomas Jones, M.D., Seattle Children’s Hospital

Global registry Shows Longer Stent Minimizes Procedure Complications in Sinus Venosus Atrial Septal Defects. Presented by Dr. Eric Rosenthal, Guy’s and St. Thomas NHS Foundation Trust in London, England

 

Other SCAI 202I News:

VIDEO: The Impact of COVID-19 on Heart Attack Patients — Interview with Payam Dehghani, M.D.

SCAI Updates Best Practices in the Cardiac Cath Lab Guidelines Document

VIDEO: Radial Hemostasis Reduced by 50 Percent With StatSeal in Combination With TR Band — Interview with Arnold Seto, M.D., and Jordan Safirstein, M.D

VIDEO: Harmony Transcatheter Pulmonary Valve Has Good Outcomes at 1 Year — Interview with Tom Jones, M.D.

Young African Americans With Coronary Disease Impacted by Non-traditional Risk Factors

VIDEO: Socioeconomic and Geographic Access to TAVR Programs is Limited — Interview with Ashwin Nathan M.D.

VIDEO: Final Results of the National Cardiogenic Shock Initiative Show 71 Percent Survival — Interview with Bill O'Neill, M.D.

VIDEO: Avoiding Higher Risk Cath Lab Patients May Not Improve Outcomes Scores — Interview with Ashwin Nathan M.D., 

Find more SCAI news and video

 

Related Late-Breaking Cardiology Presentations:

ACC 2021 Late-Breaking Presentations Announced

SCAI Announces 2020 Late-breaking Clinical Studies

 

TCT 2020 Late-breaking Study Presentations

American Heart Association 2020 Late-breaking Trial Presentations 

 

 

#SCAI2021


Related Content

News | Cardiovascular Clinical Studies

May 23, 2024 — A newly-published peer-reviewed study in the Journal of the American Heart Association, JAHA, found that ...

Home May 23, 2024
Home
News | Cardiovascular Clinical Studies

May 23, 2024 — Global Heart Hub, the international alliance of heart patient organizations, announced the first findings ...

Home May 23, 2024
Home
News | Cardiovascular Clinical Studies

May 21, 2024 — A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging ...

Home May 21, 2024
Home
News | Cardiovascular Clinical Studies

May 20, 2024 — Cardiologist Brendan Carry, MD, and a team of Danville, PA-based Geisinger Medical Center physicians have ...

Home May 20, 2024
Home
News | Cardiovascular Clinical Studies

May 18, 2024 — Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ...

Home May 18, 2024
Home
News | Cardiovascular Clinical Studies

May 17, 2024 — Royal Philips, a global leader in health technology, is presenting new retrospective study results ...

Home May 17, 2024
Home
News | Cardiovascular Clinical Studies

May 15, 2024 — A new study demonstrated parity between a minimally invasive procedure to replace the aortic valve in the ...

Home May 15, 2024
Home
News | Cardiovascular Clinical Studies

May 14, 2024 — One of the most common genetic heart diseases worldwide, hypertrophic cardiomyopathy (HCM) causes the ...

Home May 14, 2024
Home
News | Cardiovascular Clinical Studies

May 14, 2024 — An ambitious, nationwide clinical trial led by UVA Health’s Karen Johnston, MD, has provided doctors with ...

Home May 14, 2024
Home
Subscribe Now